NCT06448715View on ClinicalTrials.gov

Real-World Treatment Study of Soliris (Eculizumab)

CompletedOBSERVATIONAL

Enrollment

11

Participants

Timeline

Start Date

May 28, 2024

Primary Completion Date

January 3, 2025

Study Completion Date

January 3, 2025

Conditions

Observational

Trial Locations (2)

Unknown

Research Site, Goyang-si

Research Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY